University of Basel

Department of
Biomedicine

Search

News

RSS
.
/ News, Research

Microdosing LSD for ADHD: No Therapeutic Benefit Found (Liechti Lab)

LSD is widely known as a hallucinogenic drug, but is increasingly being studied for its potential to treat mental disorders. Researchers have now systematically tested whether microdoses of LSD can alleviate symptoms of attention deficit…

.
/ News, Research

Cartilage implants offer hope for knee injuries (Barbero Lab and Martin Lab)

Researchers at the Department of Biomedicine, together with colleagues at the University Hospital Basel and other centers in Germany, Italy and Croatia, have developed cartilage implants from nasal septum cells that offer a promising…

.
/ News, Research

PROX1 Maintains Hepatocyte Identity and Prevents Liver Cancer by Suppressing Cell Fate Plasticity (Zaugg Lab)

A groundbreaking study co-led by postdoctoral researcher Aryan Kamal of the Zaugg lab, affiliated with the EMBL in Heidelberg and our Department of Biomedicine, in collaboration with Bryce Lim in Moritz Mall’s labat the German Cancer…

.
/ News, Research

Durable Lymphocyte Subset Elimination to Decipher Immune Control of Chronic Viral Infection (Pinschewer lab)

In her recently published work, Anna Lena Kastner and colleagues have developed a novel tool to durably eliminate lymphocyte subsets in mice, and have used this tool to decipher how antibody-producing B cells and cytotoxic T cells cooperate…

New Approach to Treat Patients with Checkpoint Inhibitor-induced Adverse Events (Apostolova Lab)
/ News, Research

New Approach to Treat Patients with Checkpoint Inhibitor-induced Adverse Events (Apostolova Lab)

Immune checkpoint inhibitors (ICI), such as anti-PD-1 and anti-CTLA4 antibodies, enhance anti-cancer immunity and are a potent treatment for several types of cancer. However, overt activation of the immune system can also cause severe…

Social Media

To top